![Anthony Polverino](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anthony Polverino
Directeur/Bestuurslid bij
BRAINSTORM CELL THERAPEUTICS INC.
Vermogen: 19 298 $ op 31-05-2026
Profiel
Dr. Anthony J.
Polverino is an Independent Director at Brainstorm Cell Therapeutics, Inc. He is on the Board of Directors at Brainstorm Cell Therapeutics, Inc. Dr. Polverino was previously employed as a Chief Scientific Officer & EVP-Early Development by Zymeworks BC, Inc., a Chief Scientific Officer by Kite Pharma, Inc., an Executive Director-Therapeutic Innovation Unit by Amgen, Inc., and a Chief Scientific Officer & EVP-Early Development by Zymeworks, Inc. He received his undergraduate degree from the University of Adelaide and a doctorate degree from Flinders University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 26-02-2026 | 25.730 ( 0,23% ) | 19 298 $ | 31-05-2026 |
Actieve functies van Anthony Polverino
| Bedrijven | Functie | Begin |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Directeur/Bestuurslid | 05-02-2018 |
Eerdere bekende functies van Anthony Polverino
| Bedrijven | Functie | Einde |
|---|---|---|
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Hoofd Techniek/Wetenschap/O&O | 19-01-2022 |
| KITE PHARMA INC | Hoofd Techniek/Wetenschap/O&O | 01-01-2018 |
| ZYMEWORKS INC. | Hoofd Techniek/Wetenschap/O&O | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Opleiding van Anthony Polverino
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
42
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Brainstorm Cell Therapeutics, Inc.
 Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
University of Adelaide
 University of Adelaide Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flinders University
 Flinders University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
